Atlas Trials

Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis

Clinical trial NCT02663895 · COMPLETED

Trial details

NCT number
NCT02663895
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Systemic SclerosisCalcinosis
Start date
2016-10-01
Primary completion
2020-05-13
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.